Luigi Taranto-Montemurro, MD, on a Potential Pharmacologic Treatment for OSA
A new study analyzed how a combination of atomoxetine and oxybutynin affects obstructive sleep apnea (OSA) severity. In this podcast, one of the study’s authors, Luigi Taranto-Montemurro, MD, from Harvard Medical School and Brigham and Women's Hospital, provides insight on his findings and what they mean for the future of pharmacotherapy for OSA. For more, click here: https://www.consultant360.com/pulmonology